Results 111 to 120 of about 2,449 (142)

Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18-49 Years of Age Enrolled at Center for Indigenous Health Sites. [PDF]

open access: yesVaccines (Basel)
Hammitt LL   +16 more
europepmc   +1 more source

Streptococcus pneumoniae serotype 3 population structure in the era of conjugate vaccines, 2001-2018. [PDF]

open access: yesMicrob Genom
Cella E   +15 more
europepmc   +1 more source

Multi-strain carriage and intrahost diversity of <i>Staphylococcus aureus</i> among Indigenous adults in the USA. [PDF]

open access: yesMicrob Genom
Webb J   +10 more
europepmc   +1 more source

Scoping review protocol of E-Health interventions targeting Indigenous populations. [PDF]

open access: yesBMJ Open
Shah S   +5 more
europepmc   +1 more source

Toward Relationality in Infectious Disease Research. [PDF]

open access: yesOpen Forum Infect Dis
Chemberlin EM   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy